Languita, Jufith O.

HRN: 22-38-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2024
CEFTRIAXONE 1G (VIAL)
08/31/2024
09/06/2024
IV
2g
OD
Typhoid Fever
Waiting Final Action 
09/02/2024
AZITHROMYCIN 500MG TABLET (TAB)
09/02/2024
09/06/2024
ORAL
500mg
OD
Pneumonia
Waiting Final Action 
09/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/04/2024
10/02/2024
IV
500mg
Q 6hrs
Hepatic Abscess, Right
Waiting Final Action 
09/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2024
09/29/2024
IV
2.25
IV
Hepatic Abscess
Waiting Final Action 
09/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/11/2024
10/02/2024
IV
500mg
Q6H
Hepatic Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: